Physician profile
Thomas E St Amour
NPI 1992750079
$828.31
in general payments reported to CMS, 2019-2025
9 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.79 · 2020: $66.33 · 2022: $136 · 2023: $110 · 2024: $276 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $337.87 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $237.08 | 2020-2025 | Ekosonic, Embold Fibered |
| Stryker Corporation | $61.00 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowsaver |
| Angiodynamics, INC. | $54.72 | 2023-2024 | Schon, Solero |
| Surmodics, INC. | $42.34 | 2023 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Sirtex Medical INC | $34.10 | 2022-2024 | Sir-Spheres Microspheres |
| Ekos Corporation | $29.38 | 2019 | |
| Microvention, INC. | $18.29 | 2019 | |
| Medtronic, INC. | $13.53 | 2024 | Spiderfx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas St Amour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.